Layout Table~~~~3020~3020~~

The World’s Top Ten Generic Companies~
Published by Visiongain, November 2006

Generic companies and the drugs they produce are now an important part of the major pharmaceutical markets. The growth rate in the industry is increasing, nine of the top ten fastest growing pharmaceutical companies are generic and the demand for cheaper drugs is increasing.

~Published by Visiongain, November 2006

Generic companies and the drugs they produce are now an important part of the major pharmaceutical markets. The growth rate in the industry is increasing, nine of the top ten fastest growing pharmaceutical companies are generic and the demand for cheaper drugs is increasing.

In 2004 the total world market for generic prescription drugs was $39.6bn with a growth rate of 12%. Visiongain predicts that a similar growth rate will result in 2005 and will then increase to reach a peak of 14% in the period 2008-2010. With over 39 major drugs due to lose their patent protection before 2010, generic companies are prepared to gain even further market share.

By 2010 generic revenues will have reached $83.9bn, with an overall 13.33% CAGR for the period 2004-2010, as estimated by visiongain. This is a high growth rate for any market and it is important especially when world branded drug growth rates are beginning to falter with growth rates of only 5-7% p.a. expected for the same forecast period.

The report examines the key aspects of the top ten generic companies including recent acquisitions and mergers as well as the latest financial results. It is a constantly changing market with companies merging to improve overall competitive position.

Why you should buy this report

* Examines the latest generic company strategy
* Investigates the success and failure of the Hatch-Waxman Act
* Comments on the importance of generic biopharmaceuticals
* Comparative analysis of the top ten generic companies
* Regional sales information is compared
* Key litigation issues are outlined

The companies that are examined here and the whole industry area is one that is very important to the future of the pharmaceutical industry. The strategy and movements of these companies will likley affect your business in some way. You need to pay attention to these companies, don't delay, buy this report today to find out about their impact on your industry.

Table of Contents ~The World’s Top Ten Generic Companies (Single user License PDF)|991|The World’s Top Ten Generic Companies (Department License PDF)|992|The World’s Top Ten Generic Companies (Company wide license PDF)|993|~3020~3055~~

The World Generics Market 2006-2011~
Published by Visiongain, May 2006

In sharp contrast to the branded pharmaceutical market, which has stalled in recent year, the generics market is enjoying a period of unprecedented success. In 2005 the world generics market was worth $45bn, a growth of 14% on the previous year. Visiongain expects this level of growth to continue over the forecast period of this report.

~Published by Visiongain, May 2006

In sharp contrast to the branded pharmaceutical market, which has stalled in recent year, the generics market is enjoying a period of unprecedented success. In 2005 the world generics market was worth $45bn, a growth of 14% on the previous year. Visiongain expects this level of growth to continue over the forecast period of this report.

The loss of patent protection by 2009 of almost $80bn worth of top selling drugs will be the major driving force for this generic market growth. Additionally, as healthcare costs in the developed world continue to increase, and the growth of pharmaceutical markets in developing countries continues to grow. More generic copies of successful drugs are being sold worldwide than ever before. This report describes how this burgeoning market will change over the forecast period and highlights the important issues for both originator companies and generic drugs manufacturers.

What is the therapeutic area with the most potential for generic companies? How are branded pharmaceutical companies preparing for the increasing threat of generic penetration? What challenges do generic companies face in the coming years? Read visiongain's The World Generics Market 2006-2011 report to find out.

The following issues are covered in detail:

* A summary of the relevant legislation affecting the generics industry
* A market forecast for the world generics market 2006-2011
* An assessment of the drivers and restraints of the market during this period
* A discussion of the attitudes to generics in different regions including the US, Europe and Asia
* The issue of Biogenerics and the changes in regulations required for their success
* A review of strategies for success for originator and generics companies

Why should you buy this report?

The progress of the generic pharmaceutical market is of great importance to anyone in the pharmaceutical industry. This report provides detailed financial data and invaluable opinion about how this market will change over the important period to come.

Table of Contents ~The World Generics Market 2006-2011 (Single user License PDF)|938|The World Generics Market 2006-2011 (Department License PDF)|939|The World Generics Market 2006-2011 (Company wide license PDF)|940|~3020~3021~~